Ludwig Enterprises (LUDG) EBIT Margin (2024)
Ludwig Enterprises (LUDG) reported EBIT Margin of 171275.36% for Q3 2024, up 95.31% quarter-over-quarter from 3655790.0% in Q1 2024.
Ludwig Enterprises (LUDG) EBIT Margin (2024) Analysis & Trends
Ludwig Enterprises has reported EBIT Margin for 1 years, with the latest figure at 171275.36% in Q3 2024.
- For the quarter ending Q3 2024, EBIT Margin changed N/A year-over-year to 171275.36%; the trailing twelve-month figure through Dec 2024 stood at 598243.78% (changed N/A YoY), and the FY2024 full-year result was 598243.78%, changed N/A from the prior year.
- EBIT Margin for Q3 2024 stood at 171275.36%, up from 3655790.0% in the prior quarter.
- The five-year high for EBIT Margin was 171275.36% in Q3 2024, with the low at 3655790.0% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Ludwig Enterprises | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -171,275.36% |
| Mar 31, 2024 | -3,655,790.00% |